Menu
Search
|

Menu

Close
X

Evolus Inc EOLS.OQ (NASDAQ Stock Exchange Global Market)

24.01 USD
-- (--)
As of Mar 22
chart
Previous Close 24.01
Open --
Volume --
3m Avg Volume 248,415
Today’s High --
Today’s Low --
52 Week High 39.50
52 Week Low 6.78
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.83 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
EPS (USD)
FY18
-1.887
FY17
-0.056
FY16
-0.335
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.54
Price to Sales (TTM)
vs sector
--
8.39
Price to Book (MRQ)
vs sector
--
5.27
Price to Cash Flow (TTM)
vs sector
--
24.12
Total Debt to Equity (MRQ)
vs sector
--
16.02
LT Debt to Equity (MRQ)
vs sector
--
11.35
Return on Investment (TTM)
vs sector
--
13.82
Return on Equity (TTM)
vs sector
--
15.24

EXECUTIVE LEADERSHIP

Vikram Malik
Chairman of the Board, Since 2018
Salary: --
Bonus: --
David Moatazedi
President, Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Lauren Silvernail
Chief Financial Officer, Executive Vice President - Corporate Development, Since 2018
Salary: --
Bonus: --
Alejandro Sabad
Vice President - Operations, Since 2018
Salary: --
Bonus: --
Kurt Knab
Vice President of Sales, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

520 Newport Center Dr Ste 1200
NEWPORT BEACH   CA   92660-7022

Phone: +1949.2844555

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.

SPONSORED STORIES